Total Payments
$13,092
2024 Payments
$1,806
Companies
33
Transactions
580
Medicare Patients
4,724
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$7,614 (58.2%)
Other$5,115 (39.1%)
Education$363.55 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,614 | 565 | 58.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,875 | 3 | 37.2% |
| Education | $363.55 | 11 | 2.8% |
| Grant | $239.52 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $7,535 | 189 | $0 (2024) |
| Amgen Inc. | $1,275 | 128 | $0 (2024) |
| Janssen Biotech, Inc. | $581.21 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $551.87 | 41 | $0 (2024) |
| PFIZER INC. | $508.93 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $422.58 | 28 | $0 (2024) |
| Horizon Therapeutics plc | $325.52 | 16 | $0 (2023) |
| Radius Health, Inc. | $261.84 | 5 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $257.21 | 19 | $0 (2024) |
| UCB, Inc. | $197.91 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,806 | 119 | ABBVIE INC. ($578.21) |
| 2023 | $2,334 | 149 | ABBVIE INC. ($575.71) |
| 2022 | $1,992 | 135 | ABBVIE INC. ($815.31) |
| 2021 | $504.84 | 61 | Amgen Inc. ($192.08) |
| 2020 | $426.12 | 45 | Amgen Inc. ($180.80) |
| 2019 | $215.05 | 14 | AbbVie, Inc. ($38.52) |
| 2018 | $5,230 | 20 | AbbVie, Inc. ($5,011) |
| 2017 | $584.10 | 37 | AbbVie, Inc. ($186.60) |
All Payment Transactions
580 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $25.91 | General |
| 12/18/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.40 | General |
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Dermatology | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: Dermatology | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,381 | 30,206 | $2.5M | $766,358 |
| 2022 | 9 | 1,256 | 4,495 | $941,760 | $298,754 |
| 2021 | 7 | 1,040 | 3,375 | $590,001 | $258,490 |
| 2020 | 5 | 1,047 | 3,107 | $558,000 | $221,621 |
Total Patients
4,724
Total Services
41,183
Medicare Billing
$1.5M
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 703 | 2,900 | $783,000 | $261,297 | 33.4% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 14 | 6,600 | $723,800 | $222,366 | 30.7% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 25 | 17,415 | $611,500 | $182,794 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 181 | 181 | $94,301 | $28,701 | 30.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 57 | 293 | $101,085 | $26,226 | 25.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 15 | 1,200 | $69,300 | $22,348 | 32.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 26 | 162 | $30,618 | $7,956 | 26.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 84 | 152 | $27,125 | $6,668 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 15 | $5,460 | $2,087 | 38.2% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 27 | 35 | $5,250 | $2,025 | 38.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 70 | $7,700 | $1,485 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $3,312 | $952.79 | 28.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 155 | 1,110 | $16,650 | $875.15 | 5.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 52 | 55 | $3,520 | $575.97 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 718 | 2,757 | $743,772 | $246,790 | 33.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 204 | 204 | $106,284 | $29,857 | 28.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 82 | 180 | $31,500 | $8,302 | 26.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 15 | 61 | $21,045 | $6,296 | 29.9% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 13 | 53 | $10,017 | $3,163 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 24 | $4,416 | $1,682 | 38.1% |
| 20550 | Injection into tendon or ligament | Office | 2022 | 23 | 23 | $3,450 | $980.17 | 28.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 134 | 1,124 | $16,860 | $947.44 | 5.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 45 | 69 | $4,416 | $736.78 | 16.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 626 | 2,446 | $502,651 | $222,455 | 44.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 182 | 182 | $57,031 | $28,499 | 50.0% |
About Dr. Arshad Mustafa, M.D
Dr. Arshad Mustafa, M.D is a Rheumatology healthcare provider based in Decatur, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740254499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arshad Mustafa, M.D has received a total of $13,092 in payments from pharmaceutical and medical device companies, with $1,806 received in 2024. These payments were reported across 580 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($7,614).
As a Medicare-enrolled provider, Mustafa has provided services to 4,724 Medicare beneficiaries, totaling 41,183 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Decatur, TX
- Active Since 02/16/2006
- Last Updated 10/06/2022
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1740254499
Products in Payments
- Humira (Biological) $1,940
- RINVOQ (Biological) $1,576
- Enbrel (Biological) $928.25
- TREMFYA (Drug) $516.41
- SKYRIZI (Biological) $497.13
- XELJANZ (Drug) $494.87
- COSENTYX (Drug) $430.79
- BENLYSTA (Biological) $422.58
- KRYSTEXXA (Biological) $360.73
- Tymlos (Biological) $261.84
- ORENCIA (Biological) $257.21
- Cimzia (Drug) $175.91
- TALTZ (Drug) $170.54
- CYLTEZO (Drug) $139.58
- COSENTYX (Biological) $121.08
- Otezla (Drug) $101.08
- HUMIRA (Biological) $91.16
- RINVOQ (Drug) $82.90
- EVENITY (Biological) $78.72
- ACTHAR (Biological) $60.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Decatur
Jefrey Lieberman, Md, MD
Rheumatology — Payments: $353,561
Rheumatology $353,561
Amir Agha, Md, MD
Rheumatology — Payments: $90,918
Rheumatology $90,918
Dr. Gary Botstein, M.d, M.D
Rheumatology — Payments: $7,376
Rheumatology $7,376
Nehemiah Tan, M.d, M.D
Rheumatology — Payments: $6,024
Rheumatology $6,024
Emily Peninger, Md, MD
Rheumatology — Payments: $3,320
Rheumatology $3,320
Manoj Kohli, Md, MD
Rheumatology — Payments: $1,351
Rheumatology $1,351